...
首页> 外文期刊>Journal of clinical periodontology >Human intrabony defect regeneration with micrografts containing dental pulp stem cells: A randomized controlled clinical trial
【24h】

Human intrabony defect regeneration with micrografts containing dental pulp stem cells: A randomized controlled clinical trial

机译:人类肠道缺陷再生再生含有牙髓干细胞的微血管:随机对照临床试验

获取原文
获取原文并翻译 | 示例

摘要

Abstract Aim The goal of this study was to evaluate if dental pulp stem cells (DPSCs) delivered into intrabony defects in a collagen scaffold would enhance the clinical and radiographic parameters of periodontal regeneration. Materials and Methods In this randomized controlled trial, 29 chronic periodontitis patients presenting one deep intrabony defect and requiring extraction of one vital tooth were consecutively enrolled. Defects were randomly assigned to test or control treatments which both consisted of the use of minimally invasive surgical technique. The dental pulp of the extracted tooth was mechanically dissociated to obtain micrografts rich in autologous DPSCs. Test sites ( n ?=?15) were filled with micrografts seeded onto collagen sponge, whereas control sites ( n ?=?14) with collagen sponge alone. Clinical and radiographic parameters were recorded at baseline, 6 and 12?months postoperatively. Results Test sites exhibited significantly more probing depth (PD) reduction (4.9?mm versus 3.4?mm), clinical attachment level (CAL) gain (4.5 versus 2.9?mm) and bone defect fill (3.9 versus 1.6?mm) than controls. Moreover, residual PD??5?mm (93% versus 50%) and CAL gain ≥4?mm (73% versus 29%) were significantly more frequent in the test group. Conclusions Application of DPSCs significantly improved clinical parameters of periodontal regeneration 1?year after treatment.
机译:摘要目的本研究的目的是评估牙科纸浆干细胞(DPSC)是否在胶原蛋白支架中的患者缺陷中的缺陷,将增强牙周再生的临床和放射线参数。连续注册该随机对照试验中的材料和方法,介绍了一个深入的患有一个深入的患者的慢性牙周炎患者和需要提取一种重要的牙齿。随机分配缺陷以测试或控制治疗,这些处理包括使用微创手术技术的使用。机械解离所提取的牙齿的牙髓,以获得富含自体DPSC的微血管。测试部位(n?=Δ15)填充到胶原海绵上的微血管,而单独使用胶原蛋白的对照位点(n?= 14)。临床和射线照相参数在基线,6和12个月被记录在术后。结果试验部位显着探测深度(Pd)减少(4.9μm,3.4毫米),临床附着水平(Cal)增益(4.5与2.9毫米)和骨缺陷填充(3.9与1.6Ωmm)比控制。此外,在试验组中,残留的Pdα<5?5μm(93%与50%)(93%相反)(73%与29%)显着更频繁。结论DPSCs的应用显着改善了治疗后牙周再生1的临床参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号